This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management of hepatic coagulopathy

Authoring team

Coagulopathy and haemorrhage are a common consequence of ALF, because of:

  • consumption, and inadequate synthesis, of clotting factors and their inhibitors
  • thrombocytopaenia

The best means of preventing or managing coagulopathy has not been clearly demonstrated:

  • fresh frozen plasma - FFP has not been proved to be effective in this context, and it is currently used only in patients who are bleeding or awaiting an invasive procedure. Infusion of a salt, water and nitrogen load may contribute to the development of cerebral oedema.

  • plasma exchange - it has been suggested that repeated courses of high-volume plasma exchange may prolong survival until liver regeneration begins, or transplantation can be performed. The beneficial effect of plasma exchange has not been confirmed in a randomised controlled trial.

  • parenteral vitamin K - improves coagulation

  • ranitidine - 50 mg in 20 ml given over 2 minutes, three times daily, to reduce stress induced erosions

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.